Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1976 May;52(607):305–308. doi: 10.1136/pgmj.52.607.305

Combination antifungal therapy for cryptococcal meningitis

J S Tobias, P F M Wrigley, Elizabeth Shaw
PMCID: PMC2496515  PMID: 959108

Abstract

Two patients with Hodgkin's disease and cryptococcal meningitis are described. Both patients were treated with a combination of the two antifungal agents, amphotericin B and flucytosine. Nephrotoxicity was easily reversible in both patients and clinical improvement was seen with this combination therapy. Intrathecal therapy with amphotericin B was used in both patients. The optimal treatment of this disease may prove to be a combination of oral flucytosine, with amphotericin B given by intrathecal injection as well as rapid low dose intravenous injection.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUTLER W. T., ALLING D. W., SPICKARD A., UTZ J. P. DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS. N Engl J Med. 1964 Jan 9;270:59–67. doi: 10.1056/NEJM196401092700201. [DOI] [PubMed] [Google Scholar]
  2. Block E. R., Bennett J. E. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proc Soc Exp Biol Med. 1973 Feb;142(2):476–480. doi: 10.3181/00379727-142-37049. [DOI] [PubMed] [Google Scholar]
  3. Devita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881–895. doi: 10.7326/0003-4819-73-6-881. [DOI] [PubMed] [Google Scholar]
  4. Diamond R. D., Bennett J. E. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med. 1973 Jan 25;288(4):186–188. doi: 10.1056/NEJM197301252880405. [DOI] [PubMed] [Google Scholar]
  5. Diamond R. D., Bennett J. E. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974 Feb;80(2):176–181. doi: 10.7326/0003-4819-80-2-176. [DOI] [PubMed] [Google Scholar]
  6. Edwards V. E., Sutherland J. M., Tyrer J. H. Cryptococcosis of the central nervous system. Epidemiological, clinical, and therapeutic features. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):415–425. doi: 10.1136/jnnp.33.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fass R. J., Perkins R. L. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses. Ann Intern Med. 1971 Apr;74(4):535–539. doi: 10.7326/0003-4819-74-4-535. [DOI] [PubMed] [Google Scholar]
  8. Fields B. T., Jr, Bates J. H., Abernathy R. S. Amphotericin B serum concentrations during therapy. Appl Microbiol. 1970 Jun;19(6):955–959. doi: 10.1128/am.19.6.955-959.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GEANEY B., HORSFALL W. R., NEILSON G. Torulosis in Queensland: report of fourteen cases. Med J Aust. 1956 Sep 8;43(10):378–382. doi: 10.5694/j.1326-5377.1956.tb56771.x. [DOI] [PubMed] [Google Scholar]
  10. Holt R. J., Newman R. L. The antimycotic activity of 5-fluorocytosine. J Clin Pathol. 1973 Mar;26(3):167–174. doi: 10.1136/jcp.26.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McGill P. E., Sequeira R., Jindani A., Nguli E. T., Forrester A. T., Fulton W. F. 5-fluorocytosine in the treatment of cryptococcal meningitis. East Afr Med J. 1969 Dec;46(12):663–668. [PubMed] [Google Scholar]
  12. Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
  13. Medoff G., Kobayashi G. S., Kwan C. N., Schlessinger D., Venkov P. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A. 1972 Jan;69(1):196–199. doi: 10.1073/pnas.69.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ommaya A. K. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet. 1963 Nov 9;2(7315):983–984. doi: 10.1016/s0140-6736(63)90681-0. [DOI] [PubMed] [Google Scholar]
  15. SPICKARD A., BUTLER W. T., ANDRIOLE V., UTZ J. P. The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann Intern Med. 1963 Jan;58:66–83. doi: 10.7326/0003-4819-58-1-66. [DOI] [PubMed] [Google Scholar]
  16. Symmers W. S. Amphotericin pharmacophobia. Br Med J. 1973 Nov 24;4(5890):460–463. doi: 10.1136/bmj.4.5890.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tassel D., Madoff M. A. Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent. JAMA. 1968 Oct 21;206(4):830–832. [PubMed] [Google Scholar]
  18. Utz J. P. Flucytosine. N Engl J Med. 1972 Apr 6;286(14):777–778. doi: 10.1056/NEJM197204062861412. [DOI] [PubMed] [Google Scholar]
  19. Vandevelde A. G., Mauceri A. A., Johnson J. E., 3rd 5-fluorocytosine in the treatment of mycotic infections. Ann Intern Med. 1972 Jul;77(1):43–51. doi: 10.7326/0003-4819-77-1-43. [DOI] [PubMed] [Google Scholar]
  20. Weese W. C., Schope R. W. 5-Fluorocytosine therapy. Ann Intern Med. 1972 Dec;77(6):1003–1004. doi: 10.7326/0003-4819-77-6-1003. [DOI] [PubMed] [Google Scholar]
  21. Witorsch P., Williams T. W., Jr, Ommaya A. K., Utz J. P. Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA. 1965 Nov 15;194(7):699–702. doi: 10.1001/jama.194.7.699. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES